Strongyloides sp.: Strongyloides stercoralis (Bavay 1876) and Strongyloides fuelleborni (Von Linstow 1905)

  • Dickson D. Despommier
  • Robert W. Gwadz
  • Peter J. Hotez


Strongyloides stercoralis is an intestinal nematode found throughout the tropical and subtropical world. It is also present in certain temperate zones, including North America where it has been reported with a high frequency among Southeast Asian immigrants and in parts of Appalachia.1,3 Dogs and nonhuman primates can harbor Strongyloides, and there have been zoonotic outbreaks of this infection among animal handlers.2 S. stercoralis can exist in a nonparasitic, free-living state in the soil, so there are many potential sources of human infection with this pathogen.


Adult Worm Parasitic Female Parasitic Phase Southeast Asian Refugee Bismuth Subnitrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gyorkos TW, Genta RM, Viens P, Maclean JD: Seroepidemiology of Strongyloides infection in the Southeast Asian refugee population in Canada. Am J Epidemiol 132:257–264, 1990PubMedGoogle Scholar
  2. 2.
    Georgi JR, Sprinkle CL: A case of human strong--yloidosis apparently contracted from asymptom-atic colony dogs. Am J Trop Med Hyg 23: 899–901, 1974PubMedGoogle Scholar
  3. 3.
    Genta RM, Weesner R, Douce RW, et al: Strongyloidiasis in US veterans of the Vietnam and other wars. JAMA 258:49–52, 1987PubMedCrossRefGoogle Scholar
  4. 4.
    Ashford RW, Vince JD, Gratten MJ, Miles WE: Strong-yloides infection associated with acute infantile disease in Papua, New Guinea. Trans R Soc Trop Med Hyg 72:554, 1978PubMedCrossRefGoogle Scholar
  5. 5.
    Barnish G, Ashford RW: Strongyloides cf. fuelleborni and hookworm in Papua, New Guinea: Patterns of infection within the community. Trans R Soc Trop Med Hyg 83:684–688, 1989PubMedCrossRefGoogle Scholar
  6. 6.
    Bavay A: Sur Tanguillule stercorale. C R Acad Sci (Paris) 83:694–696, 1876Google Scholar
  7. 7.
    Normand LA: Sur la maladie dite diarrhie de Co-chinchine. C R Hebd Sean Acad Sci 83:316–318, 1876Google Scholar
  8. 8.
    Askanazy M: Über Art und Zweck der Invasion der Anguillula intestinalis in die Darmwand. Zbl Bakt [Orig] 27:569–578, 1900Google Scholar
  9. 9.
    Fuelleborn F: Untersuchungen uber den Infektionsweg bei Strongyloides und Ankylostomum und die Biologie diesen Parasiten. Arch Schiffs Trop 18:26–80, 1914Google Scholar
  10. 10.
    Nishigoii M: On various factors influencing the development of Strongyloides stercoralis and au-toinfection. Taiwan Sgakkai Zassi 27:1–56, 1928Google Scholar
  11. 11.
    Mckerrow JH, Brindley P, Brown M, et al: Strongyloides stercoralis: identification of a pro-tease whose inhibition prevents larval skin invasion. Exp Parasitol 70:134–143, 1990PubMedCrossRefGoogle Scholar
  12. 12.
    Schad GA, Aikens LM, Smith G: Strongyloides stercoralis: is there a canonical migratory route through the host ? J Parasitol 75:740–749, 1989PubMedCrossRefGoogle Scholar
  13. 13.
    Shekamer JH, Neva FA, Finn DR: Persistent strongyloidiasis in an immunodeficent patient. Am J Trop Med Hyg 31:746–751, 1982Google Scholar
  14. 14.
    Brown RC, Girardeau MHF: Transmammary passage of Strongyloides sp. larvae in the human host. Am J Trop Med Hyg 26:215–219, 1977PubMedGoogle Scholar
  15. 15.
    Genta RM, Walzer PD: Strongyloidiasis. In Walzer PD, Genta RM (eds) Parasitic infections in the Compromised Host. Marcel Dekker, New York, 1989Google Scholar
  16. 16.
    Dixon AC, Yanaghihara ET, Kwock DW, Nakamura JM: Strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection in a nonendemic area. West J Med 151:410–413, 1989PubMedGoogle Scholar
  17. 17.
    Genta RM: Dysregulation of strongyloidiasis: a new hypothesis. Clin Microbiol Rev 5:345–355, 1992PubMedGoogle Scholar
  18. 18.
    Burke JA: Strongyloidiasis in childhood. Am J Dis Child 132:1130–1136, 1978PubMedGoogle Scholar
  19. 19.
    Berk SL, Verghese A, Alvarez S, et al: Clinical and epidemiologic features of strongyloidiasis, a prospective study in rural Tennessee. Arch In-tern Med 147:1257–1261, 1987Google Scholar
  20. 20.
    Von Küster LC, Genta RM: Cutaneous manifestations of strongyloidiasis. Arch Dermatol 124: 1826–1830, 1988CrossRefGoogle Scholar
  21. 21.
    Neva FA: Biology and immunology of human strongyloidiasis. J Infect Dis 153:397–406, 1986PubMedCrossRefGoogle Scholar
  22. 22.
    Naquira C, Jimenez G, Guerra JG: Ivermectin for human strongyloidiasis and other intestinal helminths. Am J Trop Med Hyg 40:304–309, 1989PubMedGoogle Scholar
  23. 23.
    Lyagoubi M, Datry A, Mayorga R, et al: Chronic persistent strongyloidiasis cured by ivermectin. Trans R Soc Trop Med Hyg 86:541, 1992PubMedCrossRefGoogle Scholar
  24. 24.
    Genta RM: Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 11:755–767, 1989PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1995

Authors and Affiliations

  • Dickson D. Despommier
    • 1
  • Robert W. Gwadz
    • 2
  • Peter J. Hotez
    • 3
  1. 1.College of Physicians and SurgeonsColumbia University, Presbyterian HospitalNew YorkUSA
  2. 2.Laboratory of Malaria Research, National Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesdaUSA
  3. 3.Yale University School of MedicineNew HavenUSA

Personalised recommendations